- JP17th Edition *Linked to MHLW website
[March 7, 2016, the MHLW Ministerial Notification No.64]- JP17th Edition texts by section (for smaller size texts)
- JP17th Edition Errata [Issued in November 17, 2017, June 7, 2018, March 29, 2019 and April 28, 2020]
- JP 17th Edition Supplement I *Linked to MHLW website
[December 1, 2017, the MHLW Ministerial Notification No.348]- JP 17th Edition Supplement I Errata [Issued in April 28, 2020]
- JP 17th Edition Supplement II *Linked to MHLW website
[June 28, 2019, the MHLW Ministerial Notification No.49]- JP 17th Edition Supplement II Errata [Issued in April 28, 2020]
| N.B.: The Japanese Pharmacopoeia Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia.（See the General Notices 5.） |